Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

Cubist Pharms LLC

manufacturer

72/100

Cubist Pharms LLC is a manufacturer that makes prescription drugs. pharmaranks independently rates 6 of its products, with a composite rating of 3.6 out of 5 based on FDA regulatory (recall-safety) data.

Rated against independent sources·Last updated June 7, 2026·How we rate

Products (6)

Rx72/100

cubicin

Daptomycin

(4 data points)
~$623.06 /30View
Rx72/100

cubicin rf

Daptomycin

(4 data points)
~$623.06 /30View
Rx72/100

dificid

Fidaxomicin

(4 data points)
~$3903.18 /30View
Rx72/100

entereg

Alvimopan

(4 data points)
Price variesView
Rx72/100

sivextro

Tedizolid Phosphate

(4 data points)
Price variesView
Rx70/100

zerbaxa

Ceftolozane Sulfate and Tazobactam Sodium

(4 data points)
Price variesView

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

Frequently asked questions

What does Cubist Pharms LLC make?

Cubist Pharms LLC makes prescription drugs. pharmaranks independently rates 6 of its products — see the full list below.

How is Cubist Pharms LLC rated?

pharmaranks gives Cubist Pharms LLC a composite rating of 3.6 out of 5, based on FDA regulatory (recall-safety) data across its products. See the source breakdown on this page.

Where this rating comes from

Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.